Scientists investigating potential drugs to improve recovery from spinal cord injury have uncovered a promising route to new treatments. Researchers tested more than 1000 potential drugs and identified that an existing one – cimetidine – improved spinal repair in zebrafish. The drug also helped… Read More
The MDI Biological Laboratory (MDIBL) has appointed James Strickland as Director of MDI Bioscience, a new initiative focused on using non-mammalian models in early drug discovery and development. Background Strickland brings experience in pharmaceutical development to his new position, in which he will leverage… Read More
ERS Genomics and ZeClinics have announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio. ERS Genomics was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier. ZeClinics is a contract research organisation using zebrafish to carry out services… Read More
A newly discovered genetic condition caused by faulty protein synthesis which causes delayed development and learning difficulties could be treated by a compound originally isolated from human sperm, say scientists. The University of Manchester researchers, with collaborators from the UK, France and US, identified rare changes in a gene called… Read More
